We8,14 and others15–19 have shown that genetic inactivation of Nupr1 antagonizes the growth of tumors in several tissues, including pancreatic cancer8 thereby supporting a role for this protein as a promising therapeutic target for the development of therapies for pancreatic cancer. This evidence concerns the gene NUPR1 and familial pancreatic carcinoma.